Cite
HARVARD Citation
Benmebarek, M. et al. (n.d.). Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models. European journal of cancer. pp. S20-. [Online].